“Formulation and Development of HA BSA Coated NLC Containing Fisetin and Flavokawain A for the Treatment of Lung Carcinoma” (2025) Journal of Carcinogenesis, 24(8s), pp. 553–562. doi:10.64149/J.Carcinog.24.8s.553-562.